Accendra Health, Inc.
ACH
$3.23
$0.072.22%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.72B | 2.76B | 2.75B | 2.74B | 2.72B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.72B | 2.76B | 2.75B | 2.74B | 2.72B |
| Cost of Revenue | 1.47B | 1.47B | 1.45B | 1.43B | 1.42B |
| Gross Profit | 1.25B | 1.29B | 1.30B | 1.31B | 1.30B |
| SG&A Expenses | 1.06B | 1.07B | 1.07B | 1.07B | 1.08B |
| Depreciation & Amortization | 65.98M | 44.20M | 21.92M | 30.27M | 32.82M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.60B | 2.59B | 2.54B | 2.53B | 2.53B |
| Operating Income | 120.00M | 175.84M | 209.44M | 204.18M | 190.99M |
| Income Before Tax | -112.80M | -101.95M | -396.02M | -391.43M | -315.96M |
| Income Tax Expenses | -7.46M | 729.00K | 29.08M | 26.81M | 25.19M |
| Earnings from Continuing Operations | -105.34 | -102.68 | -425.10 | -418.23 | -341.15 |
| Earnings from Discontinued Operations | -976.79M | -997.96M | -915.33M | -784.70M | -24.63M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.08B | -1.10B | -1.34B | -1.20B | -365.78M |
| EBIT | 120.00M | 175.84M | 209.44M | 204.18M | 190.99M |
| EBITDA | 335.11M | 372.11M | 357.53M | 349.78M | 341.08M |
| EPS Basic | -14.06 | -14.30 | -17.42 | -15.64 | -4.76 |
| Normalized Basic EPS | -0.13 | 0.39 | 0.67 | 0.63 | 0.67 |
| EPS Diluted | -14.06 | -14.30 | -17.42 | -15.64 | -4.76 |
| Normalized Diluted EPS | -0.13 | 0.39 | 0.67 | 0.62 | 0.67 |
| Average Basic Shares Outstanding | 307.35M | 308.19M | 308.24M | 308.04M | 307.83M |
| Average Diluted Shares Outstanding | 307.35M | 308.19M | 308.24M | 309.42M | 309.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |